Secondary solid tumors after allogeneic hematopoietic SCT in Japan

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 95-100

  Yokota, A ^a   Ozawa, S ^b   Masanori, T ^c   Akiyama, H ^c   Ohshima, K ^d   Kanda, Y ^d   Takahashi, S ^e   Mori, T ^f   Nakaseko, C ^b   Onoda, M ^a   Kishi, K ^g   Doki, N ^h   Aotsuka, N ⁱ   Kanamori, H ^j   Maruta, A ^j   Sakamaki, H ^c   Okamoto, S ^f  

^a CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SAISEIKAI MAEBASHI HOSPITAL   (Japan)

ⁱ NARITA RED CROSS HOSPITAL   (Japan)

^j KANAGAWA CANCER CENTER   (Japan)

more..

Author keywords

allo SCT; chronic GVHD; late effects of transplantation; secondary solid tumors

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COLON TUMOR; CONTROLLED STUDY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; INCIDENCE; JAPAN; LUNG TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH TUMOR; OVERALL SURVIVAL; PHARYNX TUMOR; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SKIN TUMOR; SOLID TUMOR; STOMACH TUMOR; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; CHILD; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; JAPAN; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855742209     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.23     Document Type: Article

References (31)

1. Gallagher G, Forrest DL. Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer 2007; 109: 84-92. (Pubitemid 46120197)
2. Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464-471. (Pubitemid 32112860)
3. Kolb HJ, Socié G, Duell T, Van Lint MT, Tichelli A, Apperley JF et al. Malignant neoplasms in long-term survivors of bone marrow transplantation: late effects working party of the European cooperative group for blood and marrow transplantation and the European late effect project group. Ann Intern Med 1999; 131: 738-744.
4. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904. (Pubitemid 27137189)
5. Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 2005; 36: 115-121. (Pubitemid 41030626)
6. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008; 38: 641-648.
7. Vandenbroucke J. A shortcut method for calculating the 95% percent confidence interval of the standardized mortality ratio. Am J Epidemiol 1982; 115: 303-304.
8. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994; 128: 1-302.
9. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1140-1154.
10. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901-910. (Pubitemid 27198953)
11. Baker KS, DeFor TE, Burns JK, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stemcell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352-1358. (Pubitemid 46606415)
12. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833-1844. (Pubitemid 28185482)
13. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME et al. Impact of chronic GvHD therapy on the development of squamous cell cancers after hematopoietic stem cell transplantation: an international case-control study. Blood 2005; 105: 3802-3811. (Pubitemid 40662691)
14. Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141-1150. (Pubitemid 27427615)
15. Winter P, Schoeneich G, Miersch WD, Klehr HU. Tumour induction as a consequence of immunosuppression after renal transplantation. Int Urol Nephrol 1997; 29: 701-709. (Pubitemid 28050027)
16. Faber P, Fisch P, Waterhouse M, Schmitt-Gräff A, Bertz H, Finke J et al. Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans. Blood 2006; 107: 3389-3396.
17. Hasegawa W, Pond GR, Rifkind JT, Messner HA, Lau A, Daly AS et al. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 35: 51-55. (Pubitemid 40090056)
18. Leisenring W, Friedman DL, Flowers MED, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 2006; 24: 1119-1126. (Pubitemid 46638809)
19. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357. (Pubitemid 30056424)
20. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784-789. (Pubitemid 19237425)
21. Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ et al. Malignant neoplasms, following bone marrow transplantation. Blood 1996; 87: 3633-3639. (Pubitemid 26129591)
22. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13. Solid cancer and noncancer disease mortality. 1950-1997. Radiat Res 2003; 160: 381-407. (Pubitemid 37174507)
23. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-751. (Pubitemid 26089355)
24. van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18: 487-497. (Pubitemid 30078530)
25. Charles M. UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Comittee on the effects of atomic radiation. J Radiol Prot 2001; 21: 83-86.
26. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330-1336.
27. Cohen A, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28: 1125-1128. (Pubitemid 34082967)
28. Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88: 270-278. (Pubitemid 26073371)
29. Tucker MA, D'Angio GJ, Boice Jr JD, Strong LC, Li FP, Stovall M et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588-593. (Pubitemid 17126781)
30. Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87: 3625-3632. (Pubitemid 26129590)
31. Favre-Schmuziger G, Hofer S, Passweg J, Tichelli A, Hoffmann T, Speck B et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 895-898. (Pubitemid 30209684)